Percentile values of serum zinc concentration and prevalence of its deficiency in Iranian children and adolescents: the CASPIAN-V study

2020 ◽  
Vol 33 (4) ◽  
pp. 525-531
Author(s):  
Bahar Azemati ◽  
Maliheh Khoramdad ◽  
Mostafa Qorbani ◽  
Hadith Rastad ◽  
Gita Shafiee ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Zinc Deficiency ◽  
Zinc Concentration ◽  
Serum Zinc ◽  
Zinc Level ◽  
Specific Reference ◽  
P Value ◽  
Residential Areas ◽  
Serum Zinc Concentration ◽  
Iranian Children

AbstractBackgroundTo determine the prevalence of serum zinc deficiency and provide the age- and sex-specific percentile values of serum zinc in children and adolescents.MethodsWe used the gathered data through the CASPIAN-V study, a national survey conducted on 3500 students aged 7–18 years from 30 provinces of Iran. In this study, 1370 blood samples were selected randomly, and serum zinc concentration was measured using a Hitachi automated analyzer. Zinc deficiency was defined as a serum zinc level of less than 75 μg/dL. Age-sex specific reference percentile values were developed for serum zinc concentration.ResultsThe mean age of participants was 12.4 ± 3.0 years; 49.3% were girls and 73% were urban inhabitants. Mean (standard deviation [SD]) of serum zinc concentration was 107.23 (25.81) μg/dL with a significant sex difference; 109.03 ± 26.12 μg/dL for males compared to 105.41 ± 25.3 μg/dL for females (p = 0.009). The prevalence of subclinical zinc deficiency was 4.9% (95% confidence intervals [CI]: 3.0, 6.9) in children and adolescents. Both zinc deficient and sufficient groups were similar in terms of age, sex and residential areas (all p-value > 0.05). Overall, the 5th and 95th percentile values for serum zinc were 68.28 and 151.87 μg/dL, respectively. The value of all percentiles consistently decreased with age. The 10–99th percentile values for serum zinc were greater in boys than girls at all ages.ConclusionsNearly 5% of subjects had zinc deficiency. Age-sex specific percentile values were established for Iranian children and adolescents.

scholarly journals Assessment of Zinc Status Among Pregnant Women Attending a Tertiary Level Hospital of Sunsari District, Nepal

2020 ◽  
Vol 17 (4) ◽  
pp. 468-473
Author(s):  
Man Kumar Tamang ◽  
Uday Narayan Yadav ◽  
Anish Acharya ◽  
Madhab Lamsal
Keyword(s):  
Pregnant Women ◽  
Zinc Deficiency ◽  
Zinc Concentration ◽  
Serum Zinc ◽  
P Value ◽  
Tertiary Level ◽  
Zinc Status ◽  
Chi Square ◽  
Serum Zinc Concentration ◽  
Level Hospital

Background: Zinc deficiency is one of the major public health problems especially in developing countries, with an estimation of over 80% of pregnant women to be zinc deficient worldwide. Maternal zinc deficiency elevates the risk of foetal growth restriction. This study aimed to assess zinc deficiency and to examine the factors associated with zinc status among pregnant women attending a tertiary level hospital in Sunsari district, province no. one, Nepal.Methods: Pregnant women were selected by using time frame consecutive sampling at B. P. Koirala Institute of Health Sciences, Dharan from September to November 2018. Data on nutritional, socio-demographic and reproductive profiles were collected using a semi-structured questionnaire. Blood was collected from each pregnant woman to estimate serum zinc concentration by atomic absorption spectrophotometry. Association between serum zinc concentration and predictor variables were assessed using chi-square test.Results: A total of 156 women participated in the study. The prevalence of zinc deficiency among the pregnant women was 22.6%. Our data did not show association of any of the socio-demographic, nutritional and reproductive variables with serum zinc status (p-value>0.05) in chi-square. Conclusions: Zinc deficiency was found to be prevalent in our targeted population. However, community based studies need to be conducted for exploring more precise relationship between zinc status and other variables.Keywords: Nepal; nutritional factors; pregnant women; zinc status.

Serum Zinc Level in Pre-eclamptic Pregnancies: Association with Clinical Complication

1970 ◽  
Vol 39 (1) ◽  
pp. 7-10
Author(s):  
Touhida Ahsan ◽  
Razia Sultana Begum ◽  
Sheikh Naznul Islam
Keyword(s):  
Blood Pressure ◽  
Diastolic Blood Pressure ◽  
Zinc Concentration ◽  
Serum Zinc ◽  
Zinc Level ◽  
Contributory Factor ◽  
Serum Zinc Concentration ◽  
Correlative Analysis ◽  
Blood Pressures ◽  
In Pregnancy

Pre-eclampsia is one of the fatal complications in pregnancy. Zinc plays an important role in the course and eventual outcome of human pregnancy, and is essential for normal embryogenesis and fetal growth. Zinc deficiency in pregnancy is thought to be associated with pre-eclampsia. The aim of this study was, therefore, to investigate the scum zinc level in pre-eclampsia and to examine its association (if any) with pre-eclampsia. A case control study was done among 45 pre-eclamptic and 35 normotensive pregnants at their third trimester. Serum zinc concentration was determined by Atomic Absorption Flame Spectrophotometric method. Correlative analysis was made to find any correlation, of serum zinc with blood Pressure. Results showed identical Maternal and gestational age, and different gravida distribution for the patients and controls, and significantly (P<0.005) higher blood pressures (systolic and diastolic) for pre-eclampsia. Serum zinc concentration were estimated 0.65±0.09mg/L in pre-eclamsia and 0.60±0.08mg/L in pregnant controls, difference of which was insignificant (p=0.284). Correlative analysis wowed that there was a linear correlation between serum level and diastolic blood pressure, but it was found to be insignificant (r=0.158, p=0.330). It was suggested that changes in zinc status may not be an etiological or contributory factor in pre-eclamsia. Key words: Serum zinc; pre-eclampsia; diastolic blood pressure DOI: 10.3329/bmj.v39i1.6226 Bangladesh Medical Journal 2010; 39(1): 7-10

scholarly journals Influence of zinc deficiency on one year recurrence in children with nephrotic syndrome

2019 ◽  
Vol 8 (3) ◽  
pp. 243-246
Author(s):  
Fatemeh Ghafoorimehr ◽  
Mastaneh Moghtaderi ◽  
Behnaz Bazargani ◽  
Dariush Fahimi ◽  
Arash Abbasi
Keyword(s):  
Nephrotic Syndrome ◽  
Zinc Deficiency ◽  
Serum Zinc ◽  
Zinc Level ◽  
P Value ◽  
Chi Square ◽  
Mean Values ◽  
Increased Risk ◽  
Steroid Sensitive Nephrotic Syndrome ◽  
One Year

Introduction: Relapses in children with steroid sensitive nephrotic syndrome (SSNS) are common and sometimes triggered by various infections. Low zinc levels have been described in children with nephrotic states. It is supposed to that zinc deficiency might lead to dysregulation of immune system and an increased risk of infection. Objectives: This study sought to examine whether the plasma level of zinc in nephrotic patients is related to the number of relapses in these patients. Patients and Methods: Forty-three children aged 1-10 years were entered in this study. Baseline data including age, serum zinc level, number of relapses during one year was recorded. The t test and chi-square tests were used to compare the mean values and proportions respectively with significant P value (P < 0.05). Results: Forty-three children with storied sensitive nephrotic syndrome enrolled in this study. Twenty-three (53.5%) of them were male and 20 (46.5%) were female. Around 74.4 % of patients experienced relapses of nephrotic syndrome in one-year period. There was a significant relation between zinc deficiency and recurrence rate. Conclusion: Zinc deficiency is common in children suffering from nephrotic syndrome and is related to recurrence of relapses in these patients.

scholarly journals High Prevalence of Zinc Deficiency in Rural Nigerian Preschool Children: A Community-Based Cross-Sectional Study

2017 ◽  
Vol 24 (1) ◽  
pp. 31-39
Author(s):  
Amarabia N.E. Ibeawuchi ◽  
Alphonsus N. Onyiriuka ◽  
Philip O. Abiodun
Keyword(s):  
Zinc Deficiency ◽  
Rural Community ◽  
Zinc Concentration ◽  
Serum Zinc ◽  
Cross Sectional Study ◽  
Community Based ◽  
Cross Sectional ◽  
Serum Zinc Concentration ◽  
High Prevalence ◽  
Zinc Concentrations

AbstractBackground and Aims: In Nigeria, community-based epidemiological data related to the prevalence of zinc deficiency in preschool children are scarce. We assessed the prevalence of zinc deficiency and the associated socio-demographic variables in children aged between 6 and 60 months, living in a Nigerian rural community.Materials and Methods: In this cross-sectional study, the serum zinc concentrations of 252 children aged between 6 and 60 months in a rural community in Nigeria were assessed, using atomic absorption spectrophotometry. The study population was selected by multistage random sampling and at least two children were selected from every household which had children in the study age group. The socio-demographic characteristics of the subjects were obtained, using an interviewer-administered questionnaire.Results: A total of 252 children were studied, 134 (53.2%) males and 118 (46.8%) females. The mean age was 32.7±17.0 months, similar for both sexes. Overall, 220 (87.3%) had low serum zinc concentrations (less than 7.65µmol/L). According to age, the highest mean serum zinc concentration was 5.43±3.52µmol/L in children aged between 6 and 12 months. Correlation between serum zinc concentration and family size or socio-economic status (SES) showed that the smaller the family size and the higher the SES, the higher the serum zinc concentration.Conclusions: The high prevalence of low serum zinc concentration indicates that zinc deficiency is a public health problem in our rural communities, requiring public health intervention.

Serum zinc status in thalassemic adolescents attending Yangon Children Hospital, Myanmar

2020 ◽  
Author(s):  
Win-Yu Aung ◽  
Thae-Nu Htwe ◽  
Myat Thandar ◽  
Ohn Mar
Keyword(s):  
Zinc Deficiency ◽  
Day Care ◽  
Zinc Concentration ◽  
Zinc Supplementation ◽  
Care Center ◽  
Serum Zinc ◽  
Delayed Puberty ◽  
Zinc Status ◽  
Day Care Center ◽  
Serum Zinc Concentration

Background: Thalassemia constitutes a major public health problem causing a significant burden on children and their families. Zinc deficiency plays an important role in many thalassemia-related complications like growth retardation, hypogonadism and delayed puberty which are frequently noted in adolescent age. Although zinc is supplemented to thalassemic patients visiting Day Care Center, Yangon Children Hospital (YCH), Myanmar, a report concerning serum zinc level of these patients is still lacking. This study, therefore, aimed to assess serum zinc status in thalassemic adolescents attending Day Care Center, YCH. Materials and Methods: This hospital-based cross-sectional study was conducted on 99 thalassemic adolescents. Mean age of diagnosis was 5.1±2.1 years. Non-fasting serum zinc concentration was determined by atomic absorption spectrophotometry. According to National Health and Nutrition Examination Survey data, zinc deficiency was defined as serum zinc concentration < 66 μg/dL (female) and < 70 μg/dL (male). Results: Serum zinc concentration (μg/dL) was 57.35 (47.30-80.14) (median, interquartile range) with maximum, 195.05 and minimum, 28.83. Zinc deficiency was observed in 69.7% (69 out of 99; 35 males and 34 females) of the patients. The associations of zinc deficiency with gender, phenotype and the use of chelator were non-significant (P>0.05). Conclusion: In spite of zinc supplementation, nearly 70% of the thalassemic adolescents showed zinc deficiency. Zinc deficiency in these adolescents might not be related to gender, phenotypes or the use of chelator. Poor compliance to take zinc supplementation and/or irregular blood transfusion could partly be attributable to zinc deficiency in these adolescents. Providing health education on the importance of regular intake of adequate zinc is advisable and periodic evaluation of zinc levels is recommended for thalassemic adolescents.

scholarly journals Efficacy and Safety of Polaprezinc (Zinc Compound) on Zinc Deficiency: A Systematic Review and Dose–Response Meta-Analysis of Randomized Clinical Trials Using Individual Patient Data

Nutrients ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1128 ◽  
Author(s):  
Kei Furihata ◽  
Masaru Tsuchikawa ◽  
Takaki Miwa ◽  
Yuji Naito ◽  
Koji Oba ◽  
...  
Keyword(s):  
Zinc Deficiency ◽  
Dose Response ◽  
Randomized Clinical Trials ◽  
Zinc Concentration ◽  
Individual Patient Data ◽  
Serum Zinc ◽  
Response Relationship ◽  
Dose Response Relationship ◽  
Baseline Serum ◽  
Serum Zinc Concentration

Zinc intake is recommended for zinc deficiency. In clinical practice, polaprezinc has been used as a zinc replacement therapy for zinc deficiency. However, the efficacy of polaprezinc has not been established. To confirm the efficacy on zinc deficiency of polaprezinc and provide additional information on an appropriate regimen, we conducted a systematic review using individual patient data (IPD). We searched PubMed, the Japanese database Ichushi, and the database owned by the marketing authorization holder of polaprezinc. Randomized placebo-controlled trials that reported the serum zinc concentration were eligible. The mean difference of the change from baseline in serum zinc concentration was estimated using a fixed-effects model. The linear dose–response relationship and the subgroup effects were also assessed. Out of 54 unique randomized clinical trials (RCTs), four studies met the eligibility criteria, and we could access IPD for all of them. All three doses of polaprezinc (75 mg, 150 mg, and 300 mg) and the placebo group were examined. The dose-combined overall polaprezinc increased the change from baseline by a mean of 9.08 µg/dL (95% confidence interval: 5.46, 12.70; heterogeneity: I 2 = 0.61%) compared to the placebo. A significant dose–response relationship was confirmed (p < 0.001). Baseline serum zinc concentration was considered an effect modifier in polaprezinc 300 mg. All doses of polaprezinc were tolerable, but a dose–response relationship with adverse events (AEs) was observed in gastrointestinal disorders. The dose of 300 mg may be useful among patients with baseline serum zinc concentration of less than 70 µg/dL, and 150 mg for 70 µg/dL or more.

scholarly journals P619 Efficacy of zinc acetate hydrate administration for zinc deficiency in patients with inflammatory bowel disease: a multi-centre retrospective study

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S514-S515
Author(s):  
K Sakurai ◽  
T Katsurada ◽  
S Otagiri ◽  
K Yamanashi ◽  
K Nagashima ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Zinc Deficiency ◽  
Bowel Disease ◽  
Zinc Acetate ◽  
Zinc Concentration ◽  
Serum Zinc ◽  
Serum Zinc Concentration ◽  
Inflammatory Bowel ◽  
Acetate Hydrate ◽  
Observation Period

Abstract Background Zinc deficiency is common in patients with inflammatory bowel disease (IBD), and the frequency is about 42.1% in Crohn’s disease (CD) and 38.5% in ulcerative colitis (UC). Patients with IBD with serum zinc deficiency are more likely to have adverse disease-specific outcomes. However, there are few studies about the effect of administering zinc preparations in IBD patients with zinc deficiency. The purpose of this study was to investigate the efficacy of zinc acetate hydrate (Nobelzin®︎) preparation for patients with IBD with zinc deficiency. Methods 56 IBD patients who were treated with Nobelzin®︎ for zinc deficiency from March 2017 to November 2019 were analyzed. We conducted a multicenter retrospective observational study to investigate changes in serum zinc concentration or changes in disease activity before and after administration and their contributing factors. Results Among 56 cases, 4 cases were excluded due to self-interruption of internal use, and 52 cases (39 cases of CD, 13 cases of UC) were included. The median observation period was 27.5 (13–47) weeks, the median serum zinc concentration before administration was 58.5 (50.8–65.3) μg/dl, and the average of starting dose of Nobelzin®︎ was 67.8±31.1 mg/day. Nobelzin®︎ administration normalised serum zinc concentration(Zn ≥80 μg/dl) in 94.2 % (49/52) of patients. The median administration period required for normalisation of serum zinc concentration was 5 (3–8) weeks. In the group of CD patients who achieved zinc normalisation, the median CDAI score significantly improved after the normalisation from 171.5 to 129.5 (p &lt; 0.001). Similarly, the partial Mayo score in the same group of UC significantly improved after the normalisation (p = 0.035). There were 77.6 % patients who did not have additional treatment without Nobelzin®︎ administration until zinc was normalised. In CD patients of this group, the median CDAI score significantly improved after the normalisation from 152 to 120 (p = 0.029). All 3 cases in which zinc normalisation was not achieved within the observation period were CD cases, and they had a history of multiple surgeries, changes in biologics, or a long medical history. In one patient, side effects of Nobelzin®︎ administration were observed and these were abdominal discomfort and nausea. During the observation period, serum copper concentration was measured in 27 patients after administration of Nobelzin®︎, and one patient presented with copper deficiency. Conclusion Our findings show that administration of zinc acetate hydrate preparations may be effective in improving zinc deficiency and contribute to improve disease activity in IBD patients with zinc deficiency.

The prevalence of wheezing and its association with serum zinc concentration in children and adolescents in Brazil

2014 ◽  
Vol 28 (3) ◽  
pp. 293-297 ◽  
Author(s):  
Rita de Cássia Ribeiro-Silva ◽  
Rosemeire Leovigildo Fiaccone ◽  
Maurício Lima Barreto ◽  
Luce Alves da Silva ◽  
Luis Fernandes Pereira Santos ◽  
...  
Keyword(s):  
Children And Adolescents ◽  
Zinc Concentration ◽  
Serum Zinc ◽  
Serum Zinc Concentration

scholarly journals Including 60 mg Elemental Iron in a Multiple Micronutrient Supplement Blunts the Increase in Serum Zinc after 12 Weeks of Daily Supplementation in Predominantly Anemic, Nonpregnant Cambodian Women of Reproductive Age

2019 ◽  
Vol 149 (9) ◽  
pp. 1503-1510 ◽  
Author(s):  
Jeffrey B Holmes ◽  
Hou Kroeun ◽  
Lisa A Houghton ◽  
Rosalind S Gibson ◽  
Kimberly B Harding ◽  
...  
Keyword(s):  
Zinc Deficiency ◽  
Inductively Coupled Plasma ◽  
Zinc Concentration ◽  
Controlled Trial ◽  
Serum Zinc ◽  
Reproductive Age ◽  
Double Blind ◽  
Serum Zinc Concentration ◽  
Inductively Coupled ◽  
Multiple Micronutrient

ABSTRACT Background Multiple micronutrient (MMN) supplementation may result in interaction effects due to competing absorptive pathways of trace elements. Objectives The aim of this study was to investigate the effect of MMN supplementation with or without iron on serum zinc, selenium, and copper concentrations in Cambodian women. Methods In a 2 × 2 factorial double-blind randomized 12-wk trial, predominantly anemic, nonpregnant women (aged 18–45 y) received daily 60 mg of iron (Fe; n = 201); 14 other micronutrients including zinc (15 mg), selenium (65 μg), and copper (2 mg), but no iron (MMN; n = 202); 60 mg iron plus MMN (Fe + MMN; n = 206); or a placebo (n = 200). Fasting morning blood was collected at baseline and 12 wk from women in 26 villages in Kampong Chhnang province. Serum zinc, selenium, and copper concentrations (secondary outcomes of the randomized controlled trial) were measured using inductively coupled plasma mass spectrometry. Generalized linear regression was used to estimate intervention effects [β coefficient (95% CI)] for Fe (with or without MMN) and MMN (with or without Fe) after testing for the presence of an Fe × MMN interaction. Results A total of 760 women completed the trial. Zinc deficiency prevalence at baseline was 45% (inflammation-adjusted serum zinc <10.7 μmol/L). A significant Fe × MMN interaction (P = 0.02) was detected in the 2 × 2 analysis with serum zinc concentration as the outcome: the MMN group had a higher mean serum zinc concentration at 12 wk (12.3 μmol/L; 95% CI: 12.2, 12.4 μmol/L) compared with all other groups, and the Fe + MMN group had a higher mean serum zinc concentration (11.6 μmol/L; 95% CI: 11.5, 11.7 μmol/L) compared with the Fe group (11.0 μmol/L; 95% CI: 10.9, 11.0 μmol/L) and the placebo group (11.2 μmol/L; 95% CI: 11.1, 11.4 μmol/L). Conclusions The inclusion of 60 mg iron in the daily MMN formulation may be interfering with the absorption and/or metabolism of supplemental zinc in Cambodian women. This is of particular concern when MMN supplementation is implemented in populations with risk of zinc deficiency. This trial was registered at clinicaltrials.gov as NCT-02481375.

scholarly journals The Effect of Oral Zinc Therapy in Psoriasis Patients with Serum Zinc Deficiency: A Prospective Observational Study

2021 ◽  
Author(s):  
Majid Rostami Mogaddam ◽  
Nastaran safavi Ardabili ◽  
Nasrollah Maleki
Keyword(s):  
Zinc Deficiency ◽  
Thyroid Dysfunction ◽  
Serum Zinc ◽  
Treated Group ◽  
Zinc Level ◽  
P Value ◽  
Pasi Score ◽  
Group A ◽  
The Mean ◽  
Group B

Abstract Introduction: Some studies have reported an association between serum zinc levels and psoriasis. This study aimed to assess the serum zinc level and thyroid dysfunction between psoriasis patients and healthy controls. Also, we evaluated the effect of oral zinc therapy in psoriasis patients with serum zinc deficiency. Materials and Methods: A total of 100 psoriasis patients and 100 healthy age- and sex-matched volunteers were enrolled in this prospective cross-sectional study. Finally, 52 psoriasis patients with serum zinc deficiency were randomly divided into two groups: one in which clobetasol cream alone was treated (group A), and one in which clobetasol cream plus oral zinc sulfate was treated (group B). The treatment response was assessed with Psoriasis Area and Severity Index (PASI) score. Results: The mean serum zinc level in psoriasis patients and controls was 62.3 ± 14.3 μg/dL and 87.7 ± 35.2 μg/dL, respectively (P-value= .001). Serum zinc deficiency was found in 52% and 26% of psoriasis patients and control subjects, respectively. Thyroid dysfunction was found in 8% of patients with psoriasis compared with 7% in control subjects (P-value=.361). At the end of the 12th week of treatment, the mean value of % reduction from baseline values of PASI Score in group A was 23.8 ± 18.2%, whereas this was 21.31 ± 17.8% in group B (P-value=.486). Conclusion: Although the prevalence of serum zinc deficiency is higher in psoriasis patients compared with healthy subjects, oral zinc supplementation does not appear to have therapeutic benefits in these patients. Also, we could not find any relationship between thyroid dysfunction and psoriasis.

Sign in / Sign up

Export Citation Format

Share Document